Red Light Holland Expands Its Psilocybin Strategy
Red Light Holland has announced that it signed a definitive agreement with Filament Health aimed at expanding its platform for natural psychedelic drug development and microdosing innovation.
If you’re unfamiliar with Red Light Holland, the company occupies an unusual position in the psychedelics industry in that it’s built a kind of hybrid model selling legal psilocybin truffles in the Netherlands and also investing in research and partnerships aimed at developing medical-grade psychedelic products, including psilocybin microdosing capsules for emerging therapeutic markets.
It’s a strategy that management uses to generate revenue today while also positioning the company for the future medical psychedelics market.
And if you’re unfamiliar with Filament Health, this is a company that specializes in developing naturally derived psychedelic drug candidates, including botanical psilocybin extracted from mushrooms rather than synthetically produced compounds.
The new agreement is designed to combine Filament’s drug-development capabilities with Red Light Holland’s expertise in cultivation and consumer products.
The goal: accelerate research into natural psilocybin formulations and microdosing applications.
You can read more about the deal here: https://finance.yahoo.com/news/red-light-holland-signs-definitive-204000957.html